Tomáš Kotačka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tomáš Kotačka has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Aleš Machara
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo náměstí 542/2 Prague 6 160 00 Czech Republic
3 shared publications - Gabriela Panýrková
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo náměstí 542/2 Prague 6 160 00 Czech Republic
3 shared publications - Jan Konvalinka
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
3 shared publications - Kateřina Radilová
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo náměstí 542/2 Prague 6 160 00 Czech Republic
3 shared publications - Michal Kráľ
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences Flemingovo náměstí 542/2 Prague 6 160 00 Czech Republic
3 shared publications - Milan Kožíšek
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo n. 2, 166 10 Prague 6, Czech Republic
3 shared publications
Latest Publications
- 3 July 2025
- Published by Wiley in ChemMedChem
- Vol. 20 (16) , e2500452
3′‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure–Activity Relationship Analysis, and Structural Characterization of Protein Complex
- 3 July 2025
- Published by Wiley in ChemMedChem
- Vol. 20 (16) , e2500452
3′‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure–Activity Relationship Analysis, and Structural Characterization of Protein Complex
- Open Access
- 11 November 2024
- Published by Wiley in ChemMedChem
- Vol. 20 (3) , e202400577
3’‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure‐Activity Relationship Analysis, and Structural Characterization of Protein Complex
The influenza RNA‐dependent RNA polymerase harbours an endonuclease subunit characterized by a catalytic site housing two divalent metal ions. By effectively chelating both Mg2+ and Mn2+ ions, a small‐molecule inhibitor with a metal‐binding pharmacophore can halt endonuclease activity. Herein, two 3’‐dehydroxypurpurogallin‐4‐carboxamide series, namely twelve C‐4’ unsubstituted and twelve C‐4’ phenyl substituted congeners were designed and prepared to be tested as inhibitors of the metal‐dependent viral enzyme. These inhibitors were accessed through the chemoenzymatic reaction of gallic acid with either pyrocatechol or phenylpyrocatechol moderated by laccase, followed by amidation. Experimental IC50 values were determined using AlphaScreen technology, with the most potent inhibitors exhibiting IC50 values around 0.35 μM. Using X‐ray crystallography, we analyzed structure of the endonuclease in complex with one potent 3’‐dehydroxypurpurogallin‐carboxamide at 2.0 Å resolution, revealing the coordination of the compound's triad of oxygen atoms with the two metal ions in the influenza A endonuclease active site.
- 11 November 2024
- Published by Wiley in ChemMedChem
- Vol. 20 (3) , e202400577
Open Access3’‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure‐Activity Relationship Analysis, and Structural Characterization of Protein Complex
The influenza RNA‐dependent RNA polymerase harbours an endonuclease subunit characterized by a catalytic site housing two divalent metal ions. By effectively chelating both Mg2+ and Mn2+ ions, a small‐molecule inhibitor with a metal‐binding pharmacophore can halt endonuclease activity. Herein, two 3’‐dehydroxypurpurogallin‐4‐carboxamide series, namely twelve C‐4’ unsubstituted and twelve C‐4’ phenyl substituted congeners were designed and prepared to be tested as inhibitors of the metal‐dependent viral enzyme. These inhibitors were accessed through the chemoenzymatic reaction of gallic acid with either pyrocatechol or phenylpyrocatechol moderated by laccase, followed by amidation. Experimental IC50 values were determined using AlphaScreen technology, with the most potent inhibitors exhibiting IC50 values around 0.35 μM. Using X‐ray crystallography, we analyzed structure of the endonuclease in complex with one potent 3’‐dehydroxypurpurogallin‐carboxamide at 2.0 Å resolution, revealing the coordination of the compound's triad of oxygen atoms with the two metal ions in the influenza A endonuclease active site.